3rd quarter’s decent performance of 41 listed pharmaceutical companies
Domestic pharmaceutical companies have made decent performance even in the MERS crisis.
According to the data aggregated from 41 listed pharmaceutical companies which published 3rd quarter’s tentative performance by the 13th of November, they recorded double-digit increases in both operating and...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
